DOI QR코드

DOI QR Code

Two Problems With Analyzing Natriuretic Peptide Levels: Obesity and Acute Myocardial Infarction

  • Ahn, Min-Soo (Department of Cardiology, Pusan National University College of Medicine) ;
  • Yoo, Byung-Su (Department of Cardiology, Wonju College of Medicine, Yonsei University)
  • Published : 2010.11.30

Abstract

Keywords

References

  1. Maisel A, Mueller C. North American B-Type Natriuretic Peptide (BNP) Consensus Working Group. Congest Heart Fail 2008;14(4 Suppl 1):4. https://doi.org/10.1111/j.1751-7133.2008.tb00001.x
  2. Bettencourt P, Januzzi JL Jr. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure. Am J Cardiol 2008;101:67-71. https://doi.org/10.1016/j.amjcard.2007.11.026
  3. Eggers KM, Lagerqvist B, Venge P, Wallentin C, Lindahl B. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol 2009;54:357-64. https://doi.org/10.1016/j.jacc.2009.03.056
  4. Bayes-Genis A, DeFilippi C, Januzzi JL Jr. Understanding amino-terminal pro-B-type natriuretic peptide in obesity. Am J Cardiol 2008;101:89-94. https://doi.org/10.1016/j.amjcard.2007.07.079
  5. Horio T, Shimada K, Kohno M, et al. Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am Heart J 1993;126:293-9. https://doi.org/10.1016/0002-8703(93)91042-D
  6. Choi SG, Jeong MH, Ahn Y, et al. Relationship between obesity and N-terminal brain natriuretic peptide level as a prognostic value after acute myocardial infarction. Korean Circ J 2010;40:558-64. https://doi.org/10.4070/kcj.2010.40.11.558
  7. Shah K, Terracciano GJ, Jiang K, Maisel AS, Fitzgerald RL. Comparability of results between point-of-care and automated instruments to measure B-type natriuretic peptide. West J Emerg Med 2010;11:44-8.
  8. Horwich TB, Hamilton MA, Fonarow GC. B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 2006;47:85-90. https://doi.org/10.1016/j.jacc.2005.08.050
  9. Tapanainen JM, Lindgren KS, Makikallio TH, Vuolteenaho O, Leppaluoto J, Huikuri HV. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2004;43:757-63. https://doi.org/10.1016/j.jacc.2003.09.048
  10. Maisel A, Mueller C, Adams K Jr, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008;10:824-39. https://doi.org/10.1016/j.ejheart.2008.07.014
  11. Choe HM, Yoo BS, Ryu HY, et al. The early changing pattern of the B-Type natriuretic peptide concentration and its significance as a prognostic marker after acute myocardial infarction. Korean Circ J 2006;36:526-34.